Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies.
about
Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 womenDevelopment of postpartum Graves' disease and type 1 diabetes after delivery in a patient with gestational diabetes.Racial disparities in economic and clinical outcomes of pregnancy among Medicaid recipientsLifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project.Hyperemesis gravidarum and long-term mortality: a population-based cohort studyRelationship between melatonin receptor 1B and insulin receptor substrate 1 polymorphisms with gestational diabetes mellitus: a systematic review and meta-analysis.Long-term changes in glucose metabolism after gestational diabetes: a double cohort studyRisk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway.The influence of maternal islet beta-cell autoantibodies in conjunction with gestational hyperglycemia on neonatal outcomesGestational diabetes mellitus is associated with TCF7L2 gene polymorphisms independent of HLA-DQB1*0602 genotypes and islet cell autoantibodies.Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus.How can we increase postpartum glucose screening in women at high risk for gestational diabetes mellitus?Plasma Levels of the Interleukin-1-Receptor Antagonist Are Lower in Women with Gestational Diabetes Mellitus and Are Particularly Associated with Postpartum Development of Type 2 DiabetesThe risk of metabolic syndrome after gestational diabetes mellitus - a hospital-based cohort studyAutoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control reportThe diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases.Maternal outcomes and follow-up after gestational diabetes mellitusClinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes.Heterogeneity of maternal characteristics and impact on gestational diabetes (GDM) risk-Implications for universal GDM screening?Serological markers of autoimmunity in pregnant women with polycystic ovary syndrome: a pilot study.The Role of Iron in Type 1 Diabetes Etiology: A Systematic Review of New Evidence on a Long-Standing Mystery.Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up.Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women.Beliefs about health and illness in Swedish and African-born women with gestational diabetes living in Sweden.Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus.Zinc transporter 8 autoantibodies: what is their clinical relevance in gestational diabetes?Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.Genomic expression profiles of blood and placenta reveal significant immune-related pathways and categories in Chinese women with gestational diabetes mellitus.Assessing the psychological effects of prenatal screening tests for maternal and foetal conditions: a systematic reviewComprehensive Analysis of Gene Expression Profiles and DNA Methylome reveals Oas1, Ppie, Polr2g as Pathogenic Target Genes of Gestational Diabetes Mellitus
P2860
Q26748783-87DA9348-EC62-4FB2-96B1-F311A2B119D2Q33585903-269FBCBE-6CD1-4A18-9BF5-B366D54C79FBQ33689212-E66085F1-437D-45BD-AC5C-86AC6BB11BBDQ33714426-0CBC381C-66E7-4614-ADB8-FC6588EBBFD8Q33834122-6E1D3C38-D01E-420B-8D3E-7E699B1B6992Q34077057-71C2CFEB-3AC3-4E35-93B3-3EA0522C10B2Q34143943-018AFD1F-2976-4137-9457-A05B80818AD7Q34594828-ABC552AE-D2D1-45C5-8CF5-B0B03A6D65D9Q35192256-AA0345AB-600A-409F-8065-5BF4D85D9EE9Q35205805-EE7BB1D8-7969-48FB-83A6-E156E7CF0CCAQ35597022-D78A5F7C-DB23-4D32-AC0D-56E54967DED5Q35872234-3203527B-1AB8-46C9-A924-B4A0A7527A0AQ36028981-D0342658-CAF0-435F-9172-2916060BC25FQ36592092-64E4D8B7-F6A7-4A57-A837-A0B6EA5B6198Q36761582-44C638E1-D3D9-4EEB-A83E-173DA559531DQ37288640-F7B70B6A-A207-4610-A8AE-00A54FBE6F5EQ37621731-F6A56074-C221-4787-B40D-B44B3E8ECCD5Q38267786-69E1F246-714B-4CAF-AB37-4F98C29C73EEQ40129611-C32E9BDF-CCF5-44C9-87EF-14D121544B6BQ43053846-672D02DF-5805-4835-A9CD-514629BD07E4Q47793807-DDE4EF8F-4D21-4716-BC6B-41BE48E8CC62Q48229717-04C3D629-4C0D-44FC-9993-458A1EDBDB52Q48366878-B21DA316-B614-40F8-AD43-A4A3E54B69B5Q48529301-4ECC8EA7-1856-4125-9A82-A329528F730EQ50916862-F8544303-0151-4207-9461-2892336ED6E7Q51312898-487FFF3B-E745-48DD-B9A0-A0736A0B2B97Q51313665-F4FF44E1-07F9-43D5-8DBE-CF02E971F381Q54393534-042B026A-AD2D-4B77-866D-120B55C91B79Q57278480-A29EE4A7-E51C-4034-B143-E5E5FA6A2AB9Q58618243-EF2E18D7-DDD7-48C4-B1E6-8BD0A543A6D4
P2860
Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gestational diabetes identifie ...... ictive role of autoantibodies.
@ast
Gestational diabetes identifie ...... ictive role of autoantibodies.
@en
type
label
Gestational diabetes identifie ...... ictive role of autoantibodies.
@ast
Gestational diabetes identifie ...... ictive role of autoantibodies.
@en
prefLabel
Gestational diabetes identifie ...... ictive role of autoantibodies.
@ast
Gestational diabetes identifie ...... ictive role of autoantibodies.
@en
P2093
P921
P1433
P1476
Gestational diabetes identifie ...... ictive role of autoantibodies.
@en
P2093
Ilkka Y Järvelä
Jaana Juutinen
Juha S Tapanainen
Pentti Koskela
Petri Kulmala
P304
P356
10.2337/DIACARE.29.03.06.DC05-1118
P407
P577
2006-03-01T00:00:00Z